08.220.2019 - Perfect Harmony: Pharma’s MELLODY Consortium Joins Forces with NVIDIA to Supercharge AI Drug Discovery

Pharmaceutical companies have traditionally kept their data close to the vest because collaboration’s side effects may include compromising intellectual property and losing the edge over competitors. But sharing data has major perks: The more data a pharma company has at its disposal, the better equipped its researchers are to quickly identify and develop promising new Read article >

The post Perfect Harmony: Pharma’s MELLODY Consortium Joins Forces with NVIDIA to Supercharge AI Drug Discovery appeared first on The Official NVIDIA Blog.